Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WHO petition against proposals to reschedule ketamine
Ketamine
"Restrictions on its use would have a significant and negative impact on animal welfare on a global scale."

Move would prohibit ketamine's use in both human and veterinary medicine

The World Health Organisation (WHO) have launched a petition against proposals to reschedule ketamine as a controlled substance with international scope.

Several countries are lobbying to have the Commission on Narcotic Drugs re-schedule the drug. The move would effectively prohibit ketamine's use in both human and veterinary medicine.

WHO is petitioning against the proposal as they believe it will significantly undermine the ability to provide cost effective anaesthesia and analgesia in various parts of the world.

If it does go ahead, every aspect of ketamine production would have a mandated compliance and regulatory protocol attached to it. 
This would reduce the supply - because increased costs would cause some manufactures to leave the market.  It would also result in a restriction of its use to essentially experimental settings, as it would be scheduled with drugs such as LSD.

The WSAVA are concerned that, should the motion to reschedule the drug move forward, it would result in additional restrictions on access to it. 

"It could effectively remove it from veterinary use," said a spokesperson.

In a statement defining their position, the WSAVA Global Pain Council said: "Access to anesthetic and analgesic drugs is imperative for the mitigation of animal suffering and the WSAVA's Global Pain Council was created to address inequalities in both education and access to analgesic/anesthetic modalities in differing regions of the world.  

"In some regions, ketamine is the only analgesic/anesthetic agent available to the veterinary profession and is essential to enable veterinarians to perform their day-to-day activities in an ethical and humane manner.  

Restrictions on its use would have a significant and negative impact on animal welfare on a global scale.  As such, the WSAVA and its Global Pain Council lend their support to the Ketamine Fact Sheet and efforts to halt any initiatives that seek to have it rescheduled."

The WSAVA are now calling for vets to support them by letting the secretariat know of their opposition to the proposal.

"We will add you voice to the growing global small animal veterinary voice opposing this initiative," they add.

For more information on ketamine visit www.wsava.org

Image (C) Coaster420

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.